Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and

Koshiki Mino1, Satoshi Nishimura, Shogo Ninomiya

  • 1a Graduate School of Bio-Science , Nagahama Institute of Bio-Science and Technology , Nagahama , Japan.

Insights

Tissue factor pathway inhibitor-2 (TFPI-2) suppresses tumors by inhibiting matrix degradation. New research shows Lysine-specific demethylase 2 (LSD2) also regulates TFPI-2, suggesting a role in cancer.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Research

Background:

  • Tissue factor pathway inhibitor-2 (TFPI-2) is a key inhibitor of extracellular matrix degradation and a presumed tumor suppressor.
  • TFPI-2 gene transcription is epigenetically regulated by DNA promoter methylation and histone 3 lysine 4 (H3K4) methylation.
  • Lysine-specific demethylase 1 (LSD1) is known to regulate TFPI-2, but the role of LSD2 is unclear.

Purpose of the Study:

  • To investigate the involvement of LSD2 in the regulation of TFPI-2.
  • To determine if LSD2 affects TFPI-2 expression through epigenetic mechanisms.
  • To compare the roles of LSD1 and LSD2 in TFPI-2 regulation.

Main Methods:

  • Preparation of a monoclonal antibody to specifically detect LSD2.
  • siRNA-mediated knockdown of LSD1 and LSD2 in cells.
  • Measurement of TFPI-2 protein and mRNA levels.
  • Bisulfite sequencing to analyze DNA methylation of the TFPI-2 promoter.

Main Results:

  • siRNA knockdown of either LSD1 or LSD2 individually increased TFPI-2 protein and mRNA levels.
  • Simultaneous knockdown of both LSD1 and LSD2 resulted in additive increases in TFPI-2 expression.
  • TFPI-2 promoter CpG sites were found to be unmethylated, indicating regulation via histone modification rather than DNA methylation.
  • The anti-LSD2 antibody successfully distinguished LSD2 from LSD1.

Conclusions:

  • LSD2, similar to LSD1, contributes to the regulation of TFPI-2 through histone modification.
  • These findings highlight a novel epigenetic regulatory pathway for TFPI-2.
  • Further research into LSD2's role in tumor malignancy is warranted.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K